135   Ruggiero C., Altieri B., Arnold E., Siqueiros-Marquez L., Doghman-Bouguerra M., Detomas M., Durand N., Jarjat M., Kurlbaum M., Chatonnet F., Deutschbein T., Clapp C. and Lalli E. (2021). Integrative genomic analysis reveals a conserved role for prolactin signalling in the regulation of adrenal function. Clin Transl Med, 11 (11) : e630

134   Ruggiero C., Doghman-Bouguerra M. and Lalli E. (2021). How good are the current models of adrenocortical carcinoma for novel drug discovery? Expert Opin Drug Discov, () : 1-3

133   Lalli E. (2021). 'You cannot expect miracles to happen overnight': patience pays off when you wish to establish a new adrenocortical carcinoma cell line. Eur J Endocrinol, 185 (2) : C9-C11

132   Jeffers J.R., Pinto E.M., Rehg J.E., Clay M.R., Wang J., Neale G., Heath R.J., Lozano G., Lalli E., Figueiredo B.C., Pappo A.S., Rodriguez-Galindo C., Chen W., Pounds S., Ribeiro R.C. and Zambetti G.P. (2021). The Common Germline TP53-R337H Mutation Is Hypomorphic and Confers Incomplete Penetrance and Late Tumor Onset in a Mouse Model. Cancer Res, 81 (9) : 2442-2456

131   Ruggiero C. and Lalli E. (2021). Targeting the cytoskeleton against metastatic dissemination. Cancer Metastasis Rev, () :

130   Nunes-Souza E., Silveira M.E., Mendes M.C., Nagashima S., de Paula CB.V., Silva GGVC.D., Barbosa G.S., Martins J.B., Noronha L., Lenzi L., Barbosa JR.S., Donin RD.F., Moura J.F., Custódio G., Machado-Souza C., Lalli E. and Figueiredo B.C. (2020). From adrenarche to aging of adrenal zona reticularis: precocious female adrenopause onset. Endocr Connect, 9 (12) : 1212-1220

129   Hasanovic A., Simsir M., Choveau F.S., Lalli E. and Mus-Veteau I. (2020). Astemizole Sensitizes Adrenocortical Carcinoma Cells to Doxorubicin by Inhibiting Patched Drug Efflux Activity. Biomedicines, 8 (8) :

128   Doghman-Bouguerra M., Finetti P., Durand N., Parise IZ.S., Sbiera S., Cantini G., Canu L., Hescot S., Figueiredo MM.O., Komechen H., Sbiera I., Nesi G., Paci A., Al Ghuzlan A., Birnbaum D., Baudin E., Luconi M., Fassnacht M., Figueiredo B.C., Bertucci F. and Lalli E. (2020). Cancer-testis Antigen FATE1 Expression in Adrenocortical Tumors Is Associated with A Pervasive Autoimmune Response and Is A Marker of Malignancy in Adult, but Not Children, ACC. Cancers (Basel), 12 (3) :

127   Surakhy M., Wallace M., Bond E., Grochola L.F., Perez H., Di Giovannantonio M., Zhang P., Malkin D., Carter H., Parise IZ.S., Zambetti G., Komechen H., Paraizo M.M., Pagadala M.S., Pinto E.M., Lalli E., Figueiredo B.C. and Bond G.L. (2020). A common polymorphism in the retinoic acid pathway modifies adrenocortical carcinoma age-dependent incidence. Br J Cancer, 122 (8) : 1231-1241

126   Pinto E.M., Faucz F.R., Paza L.Z., Wu G., Fernandes E.S., Bertherat J., Stratakis C.A., Lalli E., Ribeiro R.C., Rodriguez-Galindo C., Figueiredo B.C. and Zambetti G.P. (2020). Germline Variants in Phosphodiesterase Genes and Genetic Predisposition to Pediatric Adrenocortical Tumors. Cancers (Basel), 12 (2) :

125   Parise IZ.S., Parise G.A., Noronha L., Surakhy M., Woiski T.D., Silva D.B., Costa TE.B., Del-Valle MHC.P., Komechen H., Rosati R., Ribeiro M.G., Nascimento M.L., Souza J.A., Andrade D.P., Paraizo M.M., Galvao MM.R., Barbosa JR.S., Barbosa M.L., Custodio G.C., Figueiredo MM.O., Fabro ALM.R., Bond G., Volante M., Lalli E. and Figueiredo B.C. (2019). The Prognostic Role of CD8(+) T Lymphocytes in Childhood Adrenocortical Carcinomas Compared to Ki-67, PD-1, PD-L1, and the Weiss Score. Cancers (Basel), 11 (11) :

124   Drozd M., Delhaye S., Maurin T., Castagnola S., Grossi M., Brau F., Jarjat M., Willemsen R., Capovilla M., Hukema R.K., Lalli E. and Bardoni B. (2019). Reduction of Fmr1 mRNA Levels Rescues Pathological Features in Cortical Neurons in a Model of FXTAS. Mol Ther Nucleic Acids, 18 () : 546-553

123   Doghman-Bouguerra M. and Lalli E. (2019). ER-mitochondria interactions: Both strength and weakness within cancer cells. Biochim Biophys Acta Mol Cell Res, 1866 (4) : 650-662

122   Poli G., Ruggiero C., Cantini G., Canu L., Baroni G., Armignacco R., Jouinot A., Santi R., Ercolino T., Ragazzon B., Assie G., Mannelli M., Nesi G., Lalli E. and Luconi M. (2018). Fascin-1 is a Novel Prognostic Biomarker Associated with Tumor Invasiveness in Adrenocortical Carcinoma. J Clin Endocrinol Metab, () :

121   Ruggiero C., Doghman-Bouguerra M., Ronco C., Benhida R., Rocchi S. and Lalli E. (2018). The GRP78/BiP inhibitor HA15 synergizes with mitotane action against adrenocortical carcinoma cells through convergent activation of ER stress pathways. Mol Cell Endocrinol, () :

120   Hasanovic A., Ruggiero C., Jung S., Rapa I., Signetti L., Ben Hadj M., Terzolo M., Beuschlein F., Volante M., Hantel C., Lalli E. and Mus-Veteau I. (2018). Targeting the multidrug transporter Patched potentiates chemotherapy efficiency on adrenocortical carcinoma in vitro and in vivo. Int J Cancer, 143 (1) : 199-211

119   Ruggiero C. and Lalli E. (2017). VAV2: a novel prognostic marker and a druggable target for adrenocortical carcinoma. Oncotarget, 8 (51) : 88257-88258

118   Lalli E. and Luconi M. (2018). The next step: mechanisms driving adrenocortical carcinoma metastasis. Endocr Relat Cancer, 25 (2) : R31-R48

117   Sbiera S., Sbiera I., Ruggiero C., Doghman-Bouguerra M., Korpershoek E., de Krijger R.R., Ettaieb H., Haak H., Volante M., Papotti M., Reimondo G., Terzolo M., Luconi M., Nesi G., Mannelli M., Libe R., Ragazzon B., Assie G., Bertherat J., Altieri B., Fadda G., Rogowski-Lehmann N., Reincke M., Beuschlein F., Fassnacht M. and Lalli E. (2017). Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma. J Clin Endocrinol Metab, 102 (9) : 3491-3498

116   Morin A., Ruggiero C., Robidel E., Doghman-Bouguerra M., Das A.T., Castellano R., Josselin E., Favier J. and Lalli E. (2017). Establishment of a mouse xenograft model of metastatic adrenocortical carcinoma. Oncotarget, 8 (31) : 51050-51057

115   Ruggiero C., Doghman-Bouguerra M., Sbiera S., Sbiera I., Parsons M., Ragazzon B., Morin A., Robidel E., Favier J., Bertherat J., Fassnacht M. and Lalli E. (2017). Dosage-dependent regulation of VAV2 expression by steroidogenic factor-1 drives adrenocortical carcinoma cell invasion. Sci Signal, 10 (469) :

114   Bardoni B., Capovilla M. and Lalli E. (2017). Modeling Fragile X syndrome in neurogenesis: An unexpected phenotype and a novel tool for future therapies. Neurogenesis (Austin), 4 (1) : e1270384

113   Doghman-Bouguerra M. and Lalli E. (2017). The ER-mitochondria couple: In life and death from steroidogenesis to tumorigenesis. Mol Cell Endocrinol, 441 () : 176-184

112   Doghman-Bouguerra M. and Lalli E. (2016). ER-mitochondria contacts find their FATE. Cell Cycle, () : 1-2

111   Doghman-Bouguerra M., Granatiero V., Sbiera S., Sbiera I., Lacas-Gervais S., Brau F., Fassnacht M., Rizzuto R. and Lalli E. (2016). FATE1 antagonizes calcium- and drug-induced apoptosis by uncoupling ER and mitochondria. EMBO Rep, 17 (9) : 1264-80

110   Ruggiero C. and Lalli E. (2016). Impact of ACTH Signaling on Transcriptional Regulation of Steroidogenic Genes. Front Endocrinol (Lausanne), 7 () : 24

109   Lalli E., Barhanin J., Zennaro M.C. and Warth R. (2016). Local Control of Aldosterone Production and Primary Aldosteronism. Trends Endocrinol Metab, 27 (3) : 123-31

108   Lalli E. (2016). Special issue on animal models in endocrine neoplasia. Mol Cell Endocrinol, 421 () : 1

107   Lalli E. and Sasano H. (2016). 5th International ACC Symposium: An Outlook to Current and Future Research on the Biology of Adrenocortical Carcinoma: Diagnostic and Therapeutic Applications. Horm Cancer, 7 (1) : 44-8

106   Lalli E. (2015). Mitotane Revisited: A New Target for an Old Drug. Endocrinology, 156 (11) : 3873-5

105   Virgone C., Lalli E., Bisogno G., Lazzari E., Roma J., Zin A., Poli E., Cecchetto G., Dall'Igna P. and Alaggio R. (2015). DAX-1 Expression in Pediatric Rhabdomyosarcomas: Another Immunohistochemical Marker Useful in the Diagnosis of Translocation Positive Alveolar Rhabdomyosarcoma. PLoS One, 10 (7) : e0133019

104   Fiorini L., Tribalat M.A., Sauvard L., Cazareth J., Lalli E., Broutin I., Thomas O.P. and Mus-Veteau I. (2015). Natural paniceins from mediterranean sponge inhibit the multidrug resistance activity of Patched and increase chemotherapy efficiency on melanoma cells. Oncotarget, 6 (26) : 22282-97

103   Lalli E. and Figueiredo B.C. (2015). Pediatric adrenocortical tumors: what they can tell us on adrenal development and comparison with adult adrenal tumors. Front Endocrinol (Lausanne), 6 () : 23

102   Ruggiero C., Doghman M. and Lalli E. (2015). How genomic studies have improved our understanding of the mechanisms of transcriptional regulation by NR5A nuclear receptors. Mol Cell Endocrinol, 408 () : 138-44

101   Bertoin F., Letouze E., Grignani P., Patey M., Rossignol S., Libe R., Pasqual C., Lardiere-Deguelte S., Hoeffel-Fornes C., Gaillard D., Previdere C., Delemer B. and Lalli E. (2015). Genome-wide paternal uniparental disomy as a cause of Beckwith-Wiedemann syndrome associated with recurrent virilizing adrenocortical tumors. Horm Metab Res, 47 (7) : 497-503

100   Bandulik S., Tauber P., Lalli E., Barhanin J. and Warth R. (2015). Two-pore domain potassium channels in the adrenal cortex. Pflugers Arch, 467 (5) : 1027-42

99   Latre de Late P., El Wakil A., Jarjat M., de Krijger R.R., Heckert L.L., Naquet P. and Lalli E. (2014). Vanin-1 inactivation antagonizes the development of adrenocortical neoplasia in Sf-1 transgenic mice. Endocrinology, 155 (7) : 2349-54

98   Lalli E. (2014). Methodological pitfalls in the study of DAX-1 function. Cell Death Dis, 5 () : e977

97   El Wakil A., Mari B., Barhanin J. and Lalli E. (2013). Genomic analysis of sexual dimorphism of gene expression in the mouse adrenal gland. Horm Metab Res, 45 (12) : 870-3

96   Doghman M., Figueiredo B.C., Volante M., Papotti M. and Lalli E. (2013). Integrative analysis of SF-1 transcription factor dosage impact on genome-wide binding and gene expression regulation. Nucleic Acids Res, 41 (19) : 8896-907

95   Doghman M. and Lalli E. (2013). Lack of long-lasting effects of mitotane adjuvant therapy in a mouse xenograft model of adrenocortical carcinoma. Mol Cell Endocrinol, 381 (1-2) : 66-9

94   Custodio G., Parise G.A., Kiesel Filho N., Komechen H., Sabbaga C.C., Rosati R., Grisa L., Parise I.Z., Pianovski M.A., Fiori C.M., Ledesma J.A., Barbosa J.R., Figueiredo F.R., Sade E.R., Ibanez H., Arram S.B., Stinghen S.T., Mengarelli L.R., Figueiredo M.M., Carvalho D.C., Avilla S.G., Woiski T.D., Poncio L.C., Lima G.F., Pontarolo R., Lalli E., Zhou Y., Zambetti G.P., Ribeiro R.C. and Figueiredo B.C. (2013). Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors. J Clin Oncol, 31 (20) : 2619-26

93   Bandulik S., Tauber P., Penton D., Schweda F., Tegtmeier I., Sterner C., Lalli E., Lesage F., Hartmann M., Barhanin J. and Warth R. (2013). Severe hyperaldosteronism in neonatal Task3 potassium channel knockout mice is associated with activation of the intraadrenal renin-angiotensin system. Endocrinology, 154 (8) : 2712-22

92   Lalli E., Doghman M., Latre de Late P., El Wakil A. and Mus-Veteau I. (2013). Beyond steroidogenesis: novel target genes for SF-1 discovered by genomics. Mol Cell Endocrinol, 371 (1-2) : 154-9

91   Duregon E., Volante M., Giorcelli J., Terzolo M., Lalli E. and Papotti M. (2013). Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates. Hum Pathol, 44 (5) : 822-8

90   Doghman M. and Lalli E. (2012). Efficacy of the novel dual PI3-kinase/mTOR inhibitor NVP-BEZ235 in a preclinical model of adrenocortical carcinoma. Mol Cell Endocrinol, 364 (1-2) : 101-4

89   El Wakil A., Bandulik S., Guy N., Bendahhou S., Zennaro M.C., Niehrs C., Mari B., Warth R., Barhanin J. and Lalli E. (2012). Dkk3 is a component of the genetic circuitry regulating aldosterone biosynthesis in the adrenal cortex. Hum Mol Genet, 21 (22) : 4922-9

88   Penton D., Bandulik S., Schweda F., Haubs S., Tauber P., Reichold M., Cong L.D., El Wakil A., Budde T., Lesage F., Lalli E., Zennaro M.C., Warth R. and Barhanin J. (2012). Task3 potassium channel gene invalidation causes low renin and salt-sensitive arterial hypertension. Endocrinology, 153 (10) : 4740-8

87   Letouze E., Sow A., Petel F., Rosati R., Figueiredo B.C., Burnichon N., Gimenez-Roqueplo A.P., Lalli E. and de Reynies A. (2012). Identity by descent mapping of founder mutations in cancer using high-resolution tumor SNP data. PLoS One, 7 (5) : e35897

86   Letouze E., Rosati R., Komechen H., Doghman M., Marisa L., Fluck C., de Krijger R.R., van Noesel M.M., Mas J.C., Pianovski M.A., Zambetti G.P., Figueiredo B.C. and Lalli E. (2012). SNP array profiling of childhood adrenocortical tumors reveals distinct pathways of tumorigenesis and highlights candidate driver genes. J Clin Endocrinol Metab, 97 (7) : E1284-93

85   Hammer G.D., Fassnacht M. and Lalli E. (2011). Adrenal cancer: clinical advances. Horm Cancer, 2 (6) : 323

84   Hammer G.D., Fassnacht M. and Lalli E. (2012). Adrenal cancer: scientific advances. Mol Cell Endocrinol, 351 (1) : 1

83   Singh P., Soon P.S., Feige J.J., Chabre O., Zhao J.T., Cherradi N., Lalli E. and Sidhu S.B. (2012). Dysregulation of microRNAs in adrenocortical tumors. Mol Cell Endocrinol, 351 (1) : 118-28

82   Boulkroun S., Samson-Couterie B., Golib-Dzib J.F., Amar L., Plouin P.F., Sibony M., Lefebvre H., Louiset E., Jeunemaitre X., Meatchi T., Benecke A., Lalli E. and Zennaro M.C. (2011). Aldosterone-producing adenoma formation in the adrenal cortex involves expression of stem/progenitor cell markers. Endocrinology, 152 (12) : 4753-63

81   Maluf D.F., de Oliveira B.H. and Lalli E. (2011). Therapy of adrenocortical cancer: present and future. Am J Cancer Res, 1 (2) : 222-232

80   Doghman M., Axelson M. and Lalli E. (2011). Potent inhibitory effect of the cyclolignan picropodophyllin (PPP) on human adrenocortical carcinoma cells proliferation. Am J Cancer Res, 1 (3) : 356-361

79   Custodio G., Taques G.R., Figueiredo B.C., Gugelmin E.S., Oliveira Figueiredo M.M., Watanabe F., Pontarolo R., Lalli E. and Torres L.F. (2011). Increased incidence of choroid plexus carcinoma due to the germline TP53 R337H mutation in southern Brazil. PLoS One, 6 (3) : e18015

78   Lalli E. (2010). Adrenal cortex ontogenesis. Best Pract Res Clin Endocrinol Metab, 24 (6) : 853-64

77   El Wakil A. and Lalli E. (2011). The Wnt/beta-catenin pathway in adrenocortical development and cancer. Mol Cell Endocrinol, 332 (1-2) : 32-7

76   El Wakil A., Doghman M., Latre De Late P., Zambetti G.P., Figueiredo B.C. and Lalli E. (2011). Genetics and genomics of childhood adrenocortical tumors. Mol Cell Endocrinol, 336 (1-2) : 169-73

75   Doghman M., Madoux F., Hodder P. and Lalli E. (2010). Identification and characterization of steroidogenic factor-1 inverse agonists. Methods Enzymol, 485 () : 3-23

74   Darcan S., Goksen D., Ozen S., Ozkinay F., Durmaz B. and Lalli E. (2011). Gonadotropin-dependent precocious puberty in a patient with X-linked adrenal hypoplasia congenita caused by a novel DAX-1 mutation. Horm Res Paediatr, 75 (2) : 153-6

73   Boulkroun S., Samson-Couterie B., Dzib J.F., Lefebvre H., Louiset E., Amar L., Plouin P.F., Lalli E., Jeunemaitre X., Benecke A., Meatchi T. and Zennaro M.C. (2010). Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism. Hypertension, 56 (5) : 885-92

72   Doghman M., El Wakil A., Cardinaud B., Thomas E., Wang J., Zhao W., Peralta-Del Valle M.H., Figueiredo B.C., Zambetti G.P. and Lalli E. (2010). Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors. Cancer Res, 70 (11) : 4666-75

71   Lalli E. (2010). Adrenocortical development and cancer: focus on SF-1. J Mol Endocrinol, 44 (6) : 301-7

70   De Moura J., Kavalec F.L., Doghman M., Rosati R., Custodio G., Lalli E., Cavallari G.M., Santa Maria J. and Figueiredo B.C. (2010). Heterozygous TP53stop146/R72P fibroblasts from a Li-Fraumeni syndrome patient with impaired response to DNA damage. Int J Oncol, 36 (4) : 983-90

69   Lalli E. and Alonso J. (2010). Targeting DAX-1 in embryonic stem cells and cancer. Expert Opin Ther Targets, 14 (2) : 169-77

68   Khalfallah O., Rouleau M., Barbry P., Bardoni B. and Lalli E. (2009). Dax-1 knockdown in mouse embryonic stem cells induces loss of pluripotency and multilineage differentiation. Stem Cells, 27 (7) : 1529-37

67   Doghman M., Cazareth J., Douguet D., Madoux F., Hodder P. and Lalli E. (2009). Inhibition of adrenocortical carcinoma cell proliferation by steroidogenic factor-1 inverse agonists. J Clin Endocrinol Metab, 94 (6) : 2178-83

66   Doghman M. and Lalli E. (2009). A matter of dosage: SF-1 in adrenocortical development and cancer. Ann Endocrinol (Paris), 70 (3) : 148-52

65   Ehrlund A., Anthonisen E.H., Gustafsson N., Venteclef N., Robertson Remen K., Damdimopoulos A.E., Galeeva A., Pelto-Huikko M., Lalli E., Steffensen K.R., Gustafsson J.A. and Treuter E. (2009). E3 ubiquitin ligase RNF31 cooperates with DAX-1 in transcriptional repression of steroidogenesis. Mol Cell Biol, 29 (8) : 2230-42

64   Bensaid M., Melko M., Bechara E.G., Davidovic L., Berretta A., Catania M.V., Gecz J., Lalli E. and Bardoni B. (2009). FRAXE-associated mental retardation protein (FMR2) is an RNA-binding protein with high affinity for G-quartet RNA forming structure. Nucleic Acids Res, 37 (4) : 1269-79

63   Ye P., Nakamura Y., Lalli E. and Rainey W.E. (2009). Differential effects of high and low steroidogenic factor-1 expression on CYP11B2 expression and aldosterone production in adrenocortical cells. Endocrinology, 150 (3) : 1303-9

62   Rosati R., Cerrato F., Doghman M., Pianovski M.A., Parise G.A., Custodio G., Zambetti G.P., Ribeiro R.C., Riccio A., Figueiredo B.C. and Lalli E. (2008). High frequency of loss of heterozygosity at 11p15 and IGF2 overexpression are not related to clinical outcome in childhood adrenocortical tumors positive for the R337H TP53 mutation. Cancer Genet Cytogenet, 186 (1) : 19-24

61   Garcia-Aragoncillo E., Carrillo J., Lalli E., Agra N., Gomez-Lopez G., Pestana A. and Alonso J. (2008). DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells. Oncogene, 27 (46) : 6034-43

60   Doghman M., Cazareth J. and Lalli E. (2008). The T cell factor/beta-catenin antagonist PKF115-584 inhibits proliferation of adrenocortical carcinoma cells. J Clin Endocrinol Metab, 93 (8) : 3222-5

59   Heitzmann D., Derand R., Jungbauer S., Bandulik S., Sterner C., Schweda F., El Wakil A., Lalli E., Guy N., Mengual R., Reichold M., Tegtmeier I., Bendahhou S., Gomez-Sanchez C.E., Aller M.I., Wisden W., Weber A., Lesage F., Warth R. and Barhanin J. (2008). Invalidation of TASK1 potassium channels disrupts adrenal gland zonation and mineralocorticoid homeostasis. EMBO J, 27 (1) : 179-87

58   Doghman M., Karpova T., Rodrigues G.A., Arhatte M., De Moura J., Cavalli L.R., Virolle V., Barbry P., Zambetti G.P., Figueiredo B.C., Heckert L.L. and Lalli E. (2007). Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer. Mol Endocrinol, 21 (12) : 2968-87

57   Zwermann O., Braun A.C., Lalli E., Sassone-Corsi P., Beuschlein F. and Reincke M. (2007). Regulation of human MC2-R gene expression by CREB, CREM, and ICER in the adrenocortical cell line Y1. Horm Metab Res, 39 (8) : 560-6

56   Doghman M., Arhatte M., Thibout H., Rodrigues G., De Moura J., Grosso S., West A.N., Laurent M., Mas J.C., Bongain A., Zambetti G.P., Figueiredo B.C., Auberger P., Martinerie C. and Lalli E. (2007). Nephroblastoma overexpressed/cysteine-rich protein 61/connective tissue growth factor/nephroblastoma overexpressed gene-3 (NOV/CCN3), a selective adrenocortical cell proapoptotic factor, is down-regulated in childhood adrenocortical tumors. J Clin Endocrinol Metab, 92 (8) : 3253-60

55   Stinghen S.T., Moura J.F., Zancanella P., Rodrigues G.A., Pianovski M.A., Lalli E., Arnold D.L., Minozzo J.C., Callefe L.G., Ribeiro R.C. and Figueiredo B.C. (2006). Specific immunoassays for placental alkaline phosphatase as a tumor marker. J Biomed Biotechnol, 2006 (5) : 56087

54   West A.N., Neale G.A., Pounds S., Figueredo B.C., Rodriguez Galindo C., Pianovski M.A., Oliveira Filho A.G., Malkin D., Lalli E., Ribeiro R. and Zambetti G.P. (2007). Gene expression profiling of childhood adrenocortical tumors. Cancer Res, 67 (2) : 600-8

53   Bechara E., Davidovic L., Melko M., Bensaid M., Tremblay S., Grosgeorge J., Khandjian E.W., Lalli E. and Bardoni B. (2007). Fragile X related protein 1 isoforms differentially modulate the affinity of fragile X mental retardation protein for G-quartet RNA structure. Nucleic Acids Res, 35 (1) : 299-306

52   Laissue P., Copelli S., Bergada I., Bergada C., Barrio G., Karaboga S., Wurtz J.M., Fellous M., Lalli E. and Veitia R.A. (2006). Partial defects in transcriptional activity of two novel DAX-1 mutations in childhood-onset adrenal hypoplasia congenita. Clin Endocrinol (Oxf), 65 (5) : 681-6

51   Gautier-Stein A., Zitoun C., Lalli E., Mithieux G. and Rajas F. (2006). Transcriptional regulation of the glucose-6-phosphatase gene by cAMP/vasoactive intestinal peptide in the intestine. Role of HNF4alpha, CREM, HNF1alpha, and C/EBPalpha. J Biol Chem, 281 (42) : 31268-78

50   Pianovski M.A., Cavalli L.R., Figueiredo B.C., Santos S.C., Doghman M., Ribeiro R.C., Oliveira A.G., Michalkiewicz E., Rodrigues G.A., Zambetti G., Haddad B.R. and Lalli E. (2006). SF-1 overexpression in childhood adrenocortical tumours. Eur J Cancer, 42 (8) : 1040-3

49   Lehmann S.G., Sassone-Corsi P. and Lalli E. (2005). Heat shock affects trafficking of DAX-1 by inducing its rapid and reversible cytoplasmic localization. Endocrine, 28 (2) : 137-44

48   Mendiola M., Carrillo J., Garcia E., Lalli E., Hernandez T., de Alava E., Tirode F., Delattre O., Garcia-Miguel P., Lopez-Barea F., Pestana A. and Alonso J. (2006). The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors. Int J Cancer, 118 (6) : 1381-9

47   Vouk K., Hudler P., Strmsnik L., Fink M., Majdic G., Zorn B., Lalli E., Sassone-Corsi P., Debeljak N., Komel R. and Rozman D. (2005). Combinations of genetic changes in the human cAMP-responsive element modulator gene: a clue towards understanding some forms of male infertility? Mol Hum Reprod, 11 (8) : 567-74

46   Dmitrieva R.I., Lalli E. and Doris P.A. (2005). Regulation of adrenocortical cardiotonic steroid production by dopamine and PKA signaling. Front Biosci, 10 () : 2489-95

45   Battista M.C., Otis M., Cote M., Laforest A., Peter M., Lalli E. and Gallo-Payet N. (2005). Extracellular matrix and hormones modulate DAX-1 localization in the human fetal adrenal gland. J Clin Endocrinol Metab, 90 (9) : 5426-31

44   Zwermann O., Beuschlein F., Lalli E., Klink A., Sassone-Corsi P. and Reincke M. (2005). Clinical and molecular evidence for DAX-1 inhibition of steroidogenic factor-1-dependent ACTH receptor gene expression. Eur J Endocrinol, 152 (5) : 769-76

43   Figueiredo B.C., Cavalli L.R., Pianovski M.A., Lalli E., Sandrini R., Ribeiro R.C., Zambetti G., DeLacerda L., Rodrigues G.A. and Haddad B.R. (2005). Amplification of the steroidogenic factor 1 gene in childhood adrenocortical tumors. J Clin Endocrinol Metab, 90 (2) : 615-9

42   Doghman M., Delagrange P., Berthelon M.C., Durand P., Naville D. and Begeot M. (2005). Sustained inhibitory effect of Agouti Related Protein on the ACTH-induced Regul Pept, 124 (1-3) : 215-9

41   Doghman M., Delagrange P., Blondet A., Berthelon M.C., Durand P., Naville D. and Begeot M. (2004). Agouti-related protein antagonizes glucocorticoid production induced Endocrinology, 145 (2) : 541-7

40   Bardoni B., Willemsen R., Weiler I.J., Schenck A., Severijnen L.A., Hindelang C., Lalli E. and Mandel J.L. (2003). NUFIP1 (nuclear FMRP interacting protein 1) is a nucleocytoplasmic shuttling protein associated with active synaptoneurosomes. Exp Cell Res, 289 (1) : 95-107

39   Manna P.R., Eubank D.W., Lalli E., Sassone-Corsi P. and Stocco D.M. (2003). Transcriptional regulation of the mouse steroidogenic acute regulatory protein gene by the cAMP response-element binding protein and steroidogenic factor 1. J Mol Endocrinol, 30 (3) : 381-97

38   Lalli E. and Sassone-Corsi P. (2003). DAX-1, an unusual orphan receptor at the crossroads of steroidogenic function and sexual differentiation. Mol Endocrinol, 17 (8) : 1445-53

37   Lehmann S.G., Wurtz J.M., Renaud J.P., Sassone-Corsi P. and Lalli E. (2003). Structure-function analysis reveals the molecular determinants of the impaired biological function of DAX-1 mutants in AHC patients. Hum Mol Genet, 12 (9) : 1063-72

36   Gevry N.Y., Lalli E., Sassone-Corsi P. and Murphy B.D. (2003). Regulation of niemann-pick c1 gene expression by the 3'5'-cyclic adenosine monophosphate pathway in steroidogenic cells. Mol Endocrinol, 17 (4) : 704-15

35   Lalli E., Ohe K., Latorre E., Bianchi M.E. and Sassone-Corsi P. (2003). Sexy splicing: regulatory interplays governing sex determination from Drosophila to mammals. J Cell Sci, 116 (Pt 3) : 441-5

34   Lehmann S.G., Lalli E. and Sassone-Corsi P. (2002). X-linked adrenal hypoplasia congenita is caused by abnormal nuclear localization of the DAX-1 protein. Proc Natl Acad Sci U S A, 99 (12) : 8225-30

33   Ohe K., Lalli E. and Sassone-Corsi P. (2002). A direct role of SRY and SOX proteins in pre-mRNA splicing. Proc Natl Acad Sci U S A, 99 (3) : 1146-51

32   Manna P.R., Dyson M.T., Eubank D.W., Clark B.J., Lalli E., Sassone-Corsi P., Zeleznik A.J. and Stocco D.M. (2002). Regulation of steroidogenesis and the steroidogenic acute regulatory protein by a member of the cAMP response-element binding protein family. Mol Endocrinol, 16 (1) : 184-99

31   Murphy B.D., Lalli E., Walsh L.P., Liu Z., Soh J., Stocco D.M. and Sassone-Corsi P. (2001). Heat shock interferes with steroidogenesis by reducing transcription of the steroidogenic acute regulatory protein gene. Mol Endocrinol, 15 (8) : 1255-63

30   Aigueperse C., Val P., Pacot C., Darne C., Lalli E., Sassone-Corsi P., Veyssiere G., Jean C. and Martinez A. (2001). SF-1 (steroidogenic factor-1), C/EBPbeta (CCAAT/enhancer binding protein), and ubiquitous transcription factors NF1 (nuclear factor 1) and Sp1 (selective promoter factor 1) are required for regulation of the mouse aldose reductase-like gene (AKR1B7) expression in adrenocortical cells. Mol Endocrinol, 15 (1) : 93-111

29   Dmitrieva R.I., Bagrov A.Y., Lalli E., Sassone-Corsi P., Stocco D.M. and Doris P.A. (2000). Mammalian bufadienolide is synthesized from cholesterol in the adrenal cortex by a pathway that Is independent of cholesterol side-chain cleavage. Hypertension, 36 (3) : 442-8

28   Lalli E., Ohe K., Hindelang C. and Sassone-Corsi P. (2000). Orphan receptor DAX-1 is a shuttling RNA binding protein associated with polyribosomes via mRNA. Mol Cell Biol, 20 (13) : 4910-21

27   Lalli E., Melner M.H., Stocco D.M. and Sassone-Corsi P. (1998). DAX-1 blocks steroid production at multiple levels. Endocrinology, 139 (10) : 4237-43

26   Reincke M., Beuschlein F., Lalli E., Arlt W., Vay S., Sassone-Corsi P. and Allolio B. (1998). DAX-1 expression in human adrenocortical neoplasms: implications for steroidogenesis. J Clin Endocrinol Metab, 83 (7) : 2597-600

25   Lalli E., Bardoni B., Zazopoulos E., Wurtz J.M., Strom T.M., Moras D. and Sassone-Corsi P. (1997). A transcriptional silencing domain in DAX-1 whose mutation causes adrenal hypoplasia congenita. Mol Endocrinol, 11 (13) : 1950-60

24   Zazopoulos E., Lalli E., Stocco D.M. and Sassone-Corsi P. (1997). DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis. Nature, 390 (6657) : 311-5

23   Monaco L., Lamas M., Tamai K., Lalli E., Zazopoulos E., Penna L., Nantel F., Foulkes N.S., Mazzucchelli C. and Sassone-Corsi P. (1997). Coupling transcription to signaling pathways: cAMP and nuclear factor cAMP-responsive element modulator. Adv Second Messenger Phosphoprotein Res, 31 () : 63-74

22   Lamas M., Lalli E., Foulkes N.S. and Sassone-Corsi P. (1996). Rhythmic transcription and autoregulatory loops: nuclear pacemaker CREM. Cold Spring Harb Symp Quant Biol, 61 () : 285-94

21   Ikeda Y., Swain A., Weber T.J., Hentges K.E., Zanaria E., Lalli E., Tamai K.T., Sassone-Corsi P., Lovell-Badge R., Camerino G. and Parker K.L. (1996). Steroidogenic factor 1 and Dax-1 colocalize in multiple cell lineages: potential links in endocrine development. Mol Endocrinol, 10 (10) : 1261-72

20   Tamai K.T., Monaco L., Alastalo T.P., Lalli E., Parvinen M. and Sassone-Corsi P. (1996). Hormonal and developmental regulation of DAX-1 expression in Sertoli cells. Mol Endocrinol, 10 (12) : 1561-9

19   Melchiorri C., Cattini L., Lalli E., Campobassi A., Marchetti C. and Facchini A. (1996). DNA ploidy analysis of squamous cell carcinomas of the oral and maxillofacial region: clinical and pathologic correlations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 82 (3) : 308-14

18   Lamas M., Monaco L., Zazopoulos E., Lalli E., Tamai K., Penna L., Mazzucchelli C., Nantel F., Foulkes N.S. and Sassone-Corsi P. (1996). CREM: a master-switch in the transcriptional response to cAMP. Philos Trans R Soc Lond B Biol Sci, 351 (1339) : 561-7

17   Lalli E., Lee J.S., Lamas M., Tamai K., Zazopoulos E., Nantel F., Penna L., Foulkes N.S. and Sassone-Corsi P. (1996). The nuclear response to cAMP: role of transcription factor CREM. Philos Trans R Soc Lond B Biol Sci, 351 (1336) : 201-9

16   Lalli E., Sassone-Corsi P. and Ceredig R. (1996). Block of T lymphocyte differentiation by activation of the cAMP-dependent signal transduction pathway. EMBO J, 15 (3) : 528-37

15   Paganelli G.M., Lalli E., Facchini A., Biasco G., Santucci R., Brandi G. and Barbara L. (1994). Flow cytometry and in vitro tritiated thymidine labeling in normal rectal mucosa of patients at high risk of colorectal cancer. Am J Gastroenterol, 89 (2) : 220-4

14   Molina C.A., Foulkes N.S., Lalli E. and Sassone-Corsi P. (1993). Inducibility and negative autoregulation of CREM: an alternative promoter directs the expression of ICER, an early response repressor. Cell, 75 (5) : 875-86

13   Delmas V., Molina C.A., Lalli E., de Groot R., Foulkes N.S., Masquilier D. and Sassone-Corsi P. (1994). Complexity and versatility of the transcriptional response to cAMP. Rev Physiol Biochem Pharmacol, 124 () : 1-28

12   Lalli E., Lee J.S., Masquilier D., Schlotter F., Foulkes N.S., Molina C.A. and Sassone-Corsi P. (1993). Nuclear response to cyclic AMP: central role of transcription factor CREM (cyclic-AMP-responsive-element modulator). Biochem Soc Trans, 21 (4) : 912-7

11   Lalli E. and Sassone-Corsi P. (1994). Signal transduction and gene regulation: the nuclear response to cAMP. J Biol Chem, 269 (26) : 17359-62

10   Zanaria E., Muscatelli F., Bardoni B., Strom T.M., Guioli S., Guo W., Lalli E., Moser C., Walker A.P., McCabe E.R. and et al... (1994). An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature, 372 (6507) : 635-41

9   Monti F., Lalli E., Bontadini A., Szymczuk S., Pini E., Tononi A., Fattori P.P., Facchini A. and Ravaioli A. (1994). Synergism between gamma interferon and doxorubicin in a human MDR colon adenocarcinoma cell line. J Chemother, 6 (5) : 337-42

8   Lauri D., De Giovanni C., Biondelli T., Lalli E., Landuzzi L., Facchini A., Nicoletti G., Nanni P., Dejana E. and Lollini P.L. (1993). Decreased adhesion to endothelial cells and matrix proteins of H-2Kb gene transfected tumour cells. Br J Cancer, 68 (5) : 862-7

7   Lalli E. and Sassone-Corsi P. (1995). Thyroid-stimulating hormone (TSH)-directed induction of the CREM gene in the thyroid gland participates in the long-term desensitization of the TSH receptor. Proc Natl Acad Sci U S A, 92 (21) : 9633-7

6   Meliconi R., Lalli E., Borzi R.M., Sturani C., Galavotti V., Gunella G., Miniero R., Facchini A. and Gasbarrini G. (1990). Idiopathic pulmonary fibrosis: can cell mediated immunity markers predict clinical outcome? Thorax, 45 (7) : 536-40

5   Mariani E., Mariani A.R., Monaco M.C., Lalli E., Vitale M. and Facchini A. (1991). Commercial serum-free media: hybridoma growth and monoclonal antibody production. J Immunol Methods, 145 (1-2) : 175-83

4   Meliconi R., Uguccioni M., Lalli E., Nesci S., Delfini C., Paradisi O., Lucarelli G., Gasbarrini G. and Facchini A. (1992). Increased serum concentrations of tumour necrosis factor in beta thalassaemia: effect of bone marrow transplantation. J Clin Pathol, 45 (1) : 61-5

3   Lalli E., Meliconi R., Conte R., Mancini A., Uguccioni M., Stefanini G.F. and Gasbarrini G. (1992). Serum markers of immune activation and liver allograft rejection. Dig Dis Sci, 37 (7) : 1116-20

2   Uguccioni M., Meliconi R., Lalli E., Nesci S., Delfini C., Lucarelli G., Gasbarrini G. and Facchini A. (1992). Serum amyloid A protein concentration in bone marrow transplantation for beta thalassaemia. J Clin Pathol, 45 (4) : 348-51

1   Mariani E., Facchini A., Honorati M.C., Lalli E., Berardesca E., Ghetti P., Marinoni S., Nuzzo F., Astaldi Ricotti G.C. and Stefanini M. (1992). Immune defects in families and patients with xeroderma pigmentosum and trichothiodystrophy. Clin Exp Immunol, 88 (3) : 376-82